ABUS icon

Arbutus Biopharma
ABUS

Overview Fund Activity

50 hedge funds and large institutions have $174M invested in Arbutus Biopharma in 2014 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+26
Holders Change %
+108.33%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
31
Increased
11
Reduced
6
Closed
5
Calls
$7.7M
Puts
$3.4M
Net Calls
+$4.3M
Net Calls Change
+$4.3M

Top Buyers

1
Wells Fargo
1
Wells Fargo
California
$17M
2
AllianceBernstein
2
AllianceBernstein
Tennessee
$9.66M
3
BA
3
BlackRock Advisors
Delaware
$8.96M
4
SCM
4
Sigma Capital Management
Connecticut
$6.45M
5
BIM
5
Bogle Investment Management
Massachusetts
$8.4M

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
PC
2
PointState Capital
New York
$0
3
OAM
3
Orinda Asset Management
California
$162K
4
B
4
Bailard
California
$2.05M
5
BBA
5
Baker Bros. Advisors
New York
$10.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
51
Sabby Management
Florida
– -$4.14M -519,200 Closed
PC
52
PointState Capital
New York
– -$2.77M -348,000 Closed
ARTA
53
A.R.T. Advisors
New York
– -$213K -26,832 Closed
SKK
54
Shepherd Kaplan Krochuk
Massachusetts
– -$139K -17,418 Closed
HCM
55
Highlander Capital Management
New Jersey
– -$15.9K -2,000 Closed
1 2
3